Lyka Labs Share Price
78.36+1.53 (+1.99%)
-22.47% past 1 Year
News
NCLT reserves order on Lyka Labs–Lyka Exports merger after tax clearance
Equity
LYKALABS
NCLT Directs Income Tax Department Response on Lyka Labs Amalgamation Plan Within 15 Days
Equity
LYKALABS
Lyka Labs: Q4 Ebitda 4.10 Crores Rupees Vs 2.00 Crores (Yoy) || Q4 Ebitda Margin 12.23% Vs 7.31% (Yoy)
Equity
LYKALABS
Lyka Labs: Q4 Cons Net Profit1.80 Crores Rupees Vs Loss 2.10 Crores (Yoy); 2.70 Crores (Qoq) || Q4 Revenue 33.40 Crores Rupees Vs 27.80 Crores (Yoy)
Equity
LYKALABS
Lyka Labs: Co Has Been Granted A Patent For Indian Patent For Its Proprietary Product, “Pregabalin Gel 8%” By Patent Office India.
Equity
LYKALABS
Lyka Labs: Q3 Ebitda 5.20 Crores Rupees Vs 6.90 Crores (Yoy) || Q3 Ebitda Margin 15.33% Vs 21.10% (Yoy)
Equity
LYKALABS
Lyka Labs: Q3 Cons Net Profit 2.70 Crores Rupees Vs 1.80 Crores (Yoy) || Q3 Revenue 33.80 Crores Rupees Vs 32.60 Crores (Yoy)
Equity
LYKALABS
Lyka Labs: Co To Consider Q3 Results On Feb 4
Equity
LYKALABS
Lyka Labs: Q2 Revenue 41.10 Crores Rupees Vs 28.00 Crores (Yoy)
Equity
LYKALABS
Lyka Labs: Q2 Cons Net Profit 2.10 Crores Rupees Vs Loss 48.60 Lakhs (Yoy)
Equity
LYKALABS
Lyka Labs: Lyka’S Patent Pending Drug Pregabalin Gel 8% W/W For The Treatment Of Diabetic Neuropathic Pain Receives Approval From Cdsco
Equity
LYKALABS
Lyka Lab: Co Alloted 26 Lakh Warrants At 139.5 Rupees/Share To Ipca Lab (Correction)
Equity
LYKALABS
Lyka Lab: Co Alloted 26 Lakh Share At 139.5 Rupees/Share To Ipca Lab
Equity
LYKALABS
Lyka Lab: Q3 Sl Net Profit 1.40 Crores Rupees Vs Loss 10.20 Crores (Yoy) || Q3 Revenue 31.40 Crores Rupees Vs 17.10 Crores (Yoy)
Equity
LYKALABS
Lyka Labs informs about change in directorate
Equity
LYKALABS
Lyka Labs informs about loss of share certificates
Equity
LYKALABS
Lyka Labs informs about issuance of duplicate share certificates
Equity
LYKALABS
Lyka Labs informs about update on scheme of amalgamation
Equity
LYKALABS
Lyka Labs - Quaterly Results
Equity
LYKALABS
Lyka Labs reports Profit after tax of Rs -29.20 Lakhs, in the September 2023 quarter
Equity
LYKALABS